The ZMYND11 gene helps control which other genes are switched on and off, especially during brain development. If it does not work properly, a person may have a condition that affects development, with delays in sitting, walking, or talking, along with speech and learning difficulties, low muscle tone, and sometimes autism features or seizures. Many people with a ZMYND11-related condition are identified through genetic testing when these early developmental differences become clear.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells use to make molecules or regulate processes in the body. Some genes provide the directions for producing proteins, which are the parts of cells that do much of the work. Others mainly guide when certain processes happen, where they take place, and how active they are. Taken together, genes affect how the body grows and works, and they can influence how you respond to food, stress, or medications. To go deeper into this subject, you can find more in the LearnHub.
Overview
ZMYND11Gene function
What if the gene works
The ZMYND11 gene helps cells control which genes are turned on or off. This supports normal development, especially in the brain.
Risk
What if the gene does not work
Variants in the ZMYND11 gene can cause a neurodevelopmental condition with delayed speech and movement, learning difficulties, and sometimes autism traits or seizures. Milder to more severe variants may affect onset, severity, and which features appear.
Treatment
What does that mean for your treatment
For now, no treatment or drug choice is guided specifically by a pathogenic or loss-of-function variant in the ZMYND11 gene. Care is supportive and based on the person’s symptoms, while the ZMYND11 gene is being studied in early cancer research as a possible biomarker and drug target.
Conditions associated with ZMYND11
Gene function
What if the gene works
In many cells, the ZMYND11 gene helps guide how genetic instructions are read. It works near DNA and the proteins that package it, helping keep gene activity organized. Understanding what the ZMYND11 gene does in your cells helps explain how normal growth and everyday cell activity stay organized.
The ZMYND11 gene helps cells adjust the activity of many other genes. Its protein acts like a regulator, keeping gene use more balanced so cells can follow the right instructions at the right time.
Its protein recognizes chemical tags on histones, the proteins that help package DNA. By reading these tags, cells can better judge which parts of the genetic code are active and how that activity should be managed.
The ZMYND11 gene supports the step where DNA instructions are copied into RNA, the working message cells use to make proteins. This helps gene messages be produced in a more orderly, controlled way.
What is a variant?
A genetic variant is a slight difference in the DNA sequence of a gene. These differences are common and help shape normal human diversity, including differences in appearance, metabolism, and the way the body responds to environmental influences. Many variants do not cause any noticeable effect and are simply part of natural genetic variation. Sometimes, though, a variant changes how a gene works more substantially and may contribute to, or cause, a genetic condition.
Genetic variants
What if the gene does not work
Variants in the ZMYND11 gene can change the protein’s shape or cut it short, which may weaken how it interacts with DNA packaging proteins and controls gene activity. This is how ZMYND11 variants affect protein function at the cell level. Milder variants may leave some activity, while more severe variants, such as changes that stop protein production early, often lead to much less working protein. In people with a ZMYND11 related condition, greater loss of function can be linked with earlier or broader developmental effects.
How variants are linked to conditions
Pathogenic variants in the ZMYND11 gene cause a rare neurodevelopmental condition often called ZMYND11-related syndrome. People with this diagnosis commonly have developmental delay or intellectual disability, with speech and language often affected, and some also have autism, behavior differences, low muscle tone, or seizures. When doctors describe how ZMYND11 variants are linked to conditions, this childhood-onset syndrome is the main confirmed association rather than a common disease risk.
A variant is not necessarily a diagnosis
Gene variants are a usual part of human biology and are common throughout the general population. Most variants do not directly affect health and instead reflect natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a confirmed diagnosis, especially when several genes and environmental factors play a role. In some situations, though, a single well-characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For ZMYND11, the main risk is having a disease-causing change in the gene itself, which is usually present from conception and is not meaningfully changed by lifestyle or environmental factors. Risk to other family members can be higher if the variant is inherited, while many cases happen for the first time in one child.
Inheritance of ZMYND11 variants
ZMYND11-related conditions usually follow an autosomal dominant inheritance pattern. This means a child can be affected if they inherit one altered copy of the ZMYND11 gene from a parent, and an affected parent has a 50% chance of passing it on in each pregnancy. In many families, though, the variant is new (de novo), so it appears in the child for the first time and is not inherited from either parent. In practical terms, how variants of the ZMYND11 gene are inherited depends on whether the variant was passed down or arose new in the child.
What does my ZMYND11 result mean for my family?
A harmful change in the ZMYND11 gene is usually linked to a dominant pattern, so close relatives such as parents, brothers, sisters, and children may also carry the same change and may wish to discuss family testing. In many families, though, the change happened new in the affected person and was not inherited from either parent. That means a ZMYND11 result does not always mean one parent has it too.
Genetic information
Genetic testing
How you find out about variants
ZMYND11 genetic testing uses a blood or saliva sample to look for variants in the ZMYND11 gene. It may be done as a single gene test, a panel for developmental conditions, or exome sequencing, which reads many genes at once. Results can show a variant linked to the condition, a harmless variant, or an uncertain result that needs expert review.
When should I consider getting a genetic test?
Consider testing for the ZMYND11 gene if a child has unexplained developmental delay, major speech delay, learning problems, autism traits, or seizures, especially with similar features in the family. A result can help explain the cause and guide care and family planning.
A genetic result is only one part of your health story
Genetic test results can be informative, but how much they reveal depends on the condition and the specific variant involved. Over time, many factors shape how the body works, including lifestyle, environment, age, and medical history. In some conditions, especially those affected by many genes, genetic information offers context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. A treatment that works well for one person may work less well for another, or may cause more side effects, because the body can absorb, break down, or respond to the drug differently. These differences are common and can influence how strongly a medicine works and how sensitive someone is to it.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect the way a person responds to medication. It looks at relationships between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes influence how strongly a drug works or how the body handles it. This information can support more informed, more individualized treatment decisions. More details on this topic are available in the LearnHub.
Drugs influenced by the ZMYND11 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so questions about side effects, new symptoms, or how well a medicine is working are best discussed with your doctor.
History
The ZMYND11 gene first drew scientific interest in the late 1990s, when researchers identified the protein it encodes under the name BS69 because it interacted with a viral protein used in laboratory studies. Early work placed it in the growing field of gene regulation, and scientists later recognized it as ZMYND11 as naming systems became more standardized. Building on this early work, scientists uncovered more about the gene by linking changes in it to certain blood cancers and, later, to a rare neurodevelopmental condition. Over time, descriptions became more precise as DNA sequencing made it easier to connect specific variants with shared clinical features. Today, the ZMYND11 gene is best known in medicine through that gradual path from basic lab discovery to human genetics.